Choi CM - Search Results

1

Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.

Cho MC, Choi CM, Kim S, Jang S, Jang S, Park CJ, Chi HS, Peyton MJ, Lee W, Chun S, Kim SW, Min WK. Cho MC, et al. Among authors: choi cm. Clin Chem Lab Med. 2011 Sep 8;50(3):565-72. doi: 10.1515/CCLM.2011.704. Clin Chem Lab Med. 2011. PMID: 21899495

2

Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.

Song JW, Oh YM, Shim TS, Kim WS, Ryu JS, Choi CM. Song JW, et al. Among authors: choi cm. Lung Cancer. 2009 Sep;65(3):333-8. doi: 10.1016/j.lungcan.2008.12.004. Epub 2009 Jan 13. Lung Cancer. 2009. PMID: 19144446

3

Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients.

Lee DH, Choi CM, Kim SW, Suh C, Lee JS. Lee DH, et al. Among authors: choi cm. Med Oncol. 2012 Jun;29(2):640-3. doi: 10.1007/s12032-011-9944-6. Epub 2011 Apr 16. Med Oncol. 2012. PMID: 21499804 Clinical Trial.

4

FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.

Yoon DH, Baek S, Choi CM, Lee DH, Suh C, Ryu JS, Moon DH, Lee JS, Kim SW. Yoon DH, et al. Among authors: choi cm. Clin Cancer Res. 2011 Aug 1;17(15):5093-100. doi: 10.1158/1078-0432.CCR-10-2791. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673067 Clinical Trial.

5

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.

Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR; Korean Thoracic Oncology Research Group (KTORG); Kim SY, Hong KM. Choi CM, et al. Among authors: choi yb. Mol Cancer. 2011 Sep 24;10:119. doi: 10.1186/1476-4598-10-119. Mol Cancer. 2011. PMID: 21943122 Free PMC article.

6

Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study.

Choi DR, Lee DH, Choi CM, Kim SW, Suh C, Lee JS. Choi DR, et al. Among authors: choi cm. Anticancer Res. 2011 Oct;31(10):3457-62. Anticancer Res. 2011. PMID: 21965761 Clinical Trial.

7

Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients.

Choi CM, Yang SC, Jo HJ, Song SY, Jeon YJ, Jang TW, Kim DJ, Jang SH, Yang SH, Kim YD, Lee KH, Jang SJ, Kim YT, Kim DK, Chung DH, Kim L, Nam HS, Cho JH, Kim HJ, Ryu JS. Choi CM, et al. Ann Oncol. 2012 Aug;23(8):2088-2093. doi: 10.1093/annonc/mdr606. Epub 2012 Feb 8. Ann Oncol. 2012. PMID: 22317771 Free article.

8

The effect of acquired cisplatin resistance on sensitivity to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer cells.

Rho JK, Choi YJ, Choi YR, Kim SY, Choi SJ, Choi CM, Na II, Lee JC. Rho JK, et al. Among authors: choi sj, choi cm, choi yr, choi yj. Oncol Res. 2011;19(10-11):471-8. doi: 10.3727/096504012x13285365944337. Oncol Res. 2011. PMID: 22715590

9

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Zhang Z, et al. Among authors: choi cm, choi yj. Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330. Nat Genet. 2012. PMID: 22751098 Free PMC article.

10

Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.

Baek S, Choi CM, Ahn SH, Lee JW, Gong G, Ryu JS, Oh SJ, Bacher-Stier C, Fels L, Koglin N, Hultsch C, Schatz CA, Dinkelborg LM, Mittra ES, Gambhir SS, Moon DH. Baek S, et al. Among authors: choi cm. Clin Cancer Res. 2012 Oct 1;18(19):5427-37. doi: 10.1158/1078-0432.CCR-12-0214. Epub 2012 Aug 14. Clin Cancer Res. 2012. PMID: 22893629 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page